Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2022

View Archived Issues

Peptide-based radiopharmaceutical with reduced kidney and healthy tissue uptake

Therapeutic effects of 177Lu-ofatumumab in lymphoma murine model

CHM-273S peptide shows promise as antidiabetic drug in rats

Pathogenic variants in PRRX1 gene associated with craniosynostosis

HISHS-3001, a novel tri-receptor agonist with improved efficacy in diabetic mice

Merck & Co. patents new GTPase KRAS inhibitors

Peking University divulges new transcription factor PU.1 inhibitors

OR-449 differentially regulates sulfation pathway genes in ACC

Vertex Pharmaceuticals discloses new CFTR modulators

Enanta Pharmaceuticals identifies new SARS-CoV-2 3C-like proteinase inhibitors

Gossamer Bio presents Janus kinase inhibitors

TULP3 mutations cause degeneration of major organs

Combinatorial analytics identifies hundreds of precise drug repositioning opportunities

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...